After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. The current market capitalization of Bristol-Myers Squibb Co is $110.40B. A total of 17.72 million shares were traded on the day, compared to an average of 16.74M shares.
In the most recent transaction, Elkins David V sold 56,000 shares of BMY for 47.33 per share on Sep 02 ’25. After the transaction, the EVP, Chief Financial Officer now owns 167,379 company shares. In a previous transaction on Sep 02 ’25, Elkins David V bought 56,000 shares at 47.30 per share.
Among the insiders who sold shares, Short Bartie Wendy disposed of 378 shares on Aug 02 ’25 at a per-share price of $44.23. This resulted in the EVP, Corporate Affairs holding 5,066 shares of BMY after the transaction. In another insider transaction, Hickey Benjamin sold 97 shares at $38.01 per share on May 09 ’25. Company shares held by the President, RayzeBio Org. now total 0.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Bristol-Myers Squibb Co pays an annual dividend of $2.48, resulting in a dividend yield of 4.57%, and it has a price to earnings (P/E) ratio of 18.31.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BMY has a high of $63.33 and a low of $42.52.
As of this writing, BMY has an earnings estimate of $1.68 per share for the current quarter. EPS was calculated based on a consensus of 19.0 estimates, with a high estimate of $2.23 per share and a lower estimate of $1.51. The company reported an EPS of $1.67 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $9.11, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.52.
